Online Only Articles

Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients

GIGA-I3 and CHU, University of Liège, Liège, Belgium
Gruppo Italiano Malattie Ematologiche Dell’Adulto GIMEMA, Rome, Rome, Italy
Gruppo Italiano Malattie Ematologiche Dell’Adulto GIMEMA, Rome, Rome, Italy
Leiden University Medical Center, Leiden, the Netherlands
Gruppo Italiano Malattie Ematologiche Dell’Adulto GIMEMA, Rome, Rome, Italy
Radboud University Medical Center, Nijmegen, the Netherlands;Currently: King’s College Hospital, London, UK
Hôtel-Dieu Hospital, Paris, France
Department of Medicine and Experimental Oncology, Torino, Italy
Gruppo Italiano Malattie Ematologiche Dell’Adulto GIMEMA, Rome, Rome, Italy
Gruppo Italiano Malattie Ematologiche Dell’Adulto GIMEMA, Rome, Rome, Italy
Gustave Roussy cancer campus Grand Paris, Villejuif, France
Ospedali Riuniti “Villa Sofia-Cervello”, Palermo, Italy
University of Florence, Firenze, Italy
Ospedale Civile, Pescara, Italy
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
Jules Bordet Institute, Brussels, Belgium
Universita La Sapienza, Rome, Italy
Universita La Sapienza, Rome, Italy
Leiden University Medical Center, Leiden, the Netherlands
Radboud University Medical Center, Nijmegen, the Netherlands
Radboud University Medical Center, Nijmegen, the Netherlands
University Tor Vergata, Rome, Italy
Hôtel-Dieu Hospital, Paris, France
EORTC Headquarters, Brussels, Belgium
Vol. 105 No. 1 (2020): January, 2020 https://doi.org/10.3324/haematol.2019.221333